Atara Biotherapeutics (ATRA) CAPEX/Revenue US GAAP (year values) |
|||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
CAPEX/Revenue, % | 52.0% | 6.60% | 14.3% | 2.74% | |||||
Changes by years, y/y, % | -45pp | +8pp | -47.6% |
Atara Biotherapeutics. CAPEX/Revenue, %
Atara Biotherapeutics. CAPEX/Revenue, changes, pp
Atara Biotherapeutics (ATRA) CAPEX/Revenue US GAAP (quarter values) |
||||||||
2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
CAPEX/Revenue, % | 32.5% | 52.1% | 13.1% | 1.03% | 0.46% | 2.74% | ||
Changes by years, y/y, % | -3pp | +49pp | +10pp | -16pp | -32pp | |||
Changes by quarters, q/q, % | +16pp | +20pp | -39pp | -12pp | -1pp |